Fulgent Genetics, Inc. (FLGT) Tops Q4 EPS by 8c

Fulgent Genetics, Inc. (NASDAQ: FLGT) reported Q4 EPS of ($0.48), $0.08 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $67.7 million versus the consensus estimate of $59.57 million.

For earnings history and earnings-related data on Fulgent Genetics, Inc. (FLGT) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• William Blair Upgrades Backblaze Inc (BLZE) to Market Perform